The Common Dreams news team works hard to bring you real news that matters—which is often about how the world is. But we also work hard to bring you the voices of visionaries who dream about how the world should be.

We believe that informed, inspired and activated people can change the world—and create a more sustainable, more just, and more peaceful future built on our common dreams.

But independent journalism and democracy itself have never been more needed yet more fragile and at risk than now. We must fight on. Please support our critical End-of-Year Campaign.

Introducing the amendment on Wednesday, Sen. Bernie Sanders asked his senate colleagues if they "have the guts finally to stand up to the pharmaceutical industry and their lobbyists and their campaign contributions and fight for the American consumer?" (Photo: Kevin Dietsch/UPI)

While the Republican Party is publicly dismantling millions of Americans' health safety net, more than a dozen Democrats late Wednesday quietly threw their weight behind Big Pharma and voted down an amendment that would have allowed pharmacists to import identical—but much less expensive—drugs from Canada and other countries.

The "power and wealth of the pharmaceutical industry and their 1,300 lobbyists and unlimited sums of money have bought the United States Congress," Sen. Bernie Sanders (I-Vt.) declared in a speech on the Senate floor while introducing the amendment, co-sponsored by Sen. Amy Klobuchar (D-Minn.), which would have been attached to the chamber's budget resolution. It came amid a flurry of legislative activity during Wednesday evening's "vote-a-rama."

"Year after year the same old takes place: the pharmaceutical industry makes more and more money and the American people pay higher ad higher prices," Sanders continued, asking his colleagues if they "have the guts finally to stand up to the pharmaceutical industry and their lobbyists and their campaign contributions and fight for the American consumer?"

It turns out, no.

In fact, 13 Democrats voted against the measure (roll call here), siding with the Republican majority and drawing sharp rebuke from observers, who pointed out that many who voted "no" receive substantial contributions from the pharmaceutical industry.

Many were particularly dismayed that Sen. Cory Booker (D-N.J.) had sided with Big Pharma after winning liberal praise for his unprecedented testimony against Attorney General nominee Sen. Jeff Sessions (R-Ala.). Notably, 12 Republicans and two Independents, including Sanders, voted for the measure.

Seventy-two percent of Americans support such a rule, according to Sanders, who noted that the price differences between the U.S. and Canada are "dramatic."

"EpiPen, for example, costs more than $600 in the United States compared to $290 in Canada for the exact same allergy treatment," a press statement from Sanders' office observed. "A popular drug for high cholesterol, Crestor, costs $730 in the U.S. but $160 across the northern border. Abilify, a drug to treat depression, is more than $2,636 for a 90-day supply in the U.S. but only $436 in Canada."

Sanders' attempt to attach such a provision to the 21st Century Cures Act last month was similarly blocked.

Should the import rule have passed, it would have been a step towards ending "the epidemic of price gouging," Sanders said, which has become a hot-button issue for many Americans who are unable to afford their prescription drugs—a point the former presidential candidate hammered home on Twitter ahead of the vote.

The epidemic of price gouging in the drug industry is an obscenity! The cost of prescriptions has become its own health hazard.

This work is licensed under a Creative Commons Attribution-Share Alike 3.0 License

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do.

Further

To those who consider Trump a reptilian shape-shifter, mazel tov: Now he officially is one. Thanks to a species-naming auction for Rainforest Trust, a small, blind, worm-like, newly discovered amphibian who buries its head in the ground will be named Dermophis donaldtrumpi. The name, says its creator, is "perfect" for the new caecilian, from the Latin for "blind...perfectly mirroring the strategic vision (Trump) has consistently shown towards climate change.”

Common Dreams brings you the news that matters.

Sign up for Newsletter

Connect With Us

Support our common dreams.

Can We Count on Your Help Today?

Common Dreams is a small nonprofit with a big mission. Every day of the week, we publish the most important breaking news & views for the progressive community. To remain an independent news source, we do not advertise, sell subscriptions or accept corporate contributions. Instead, we rely on readers like you, to provide the "people power" that fuels our work. Please help keep Common Dreams alive by making a contribution. Thank you. - Craig Brown, Co-founder